Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Welch Allyn Earns Acclaim from Frost & Sullivan for Developing Its Innovative Diagnostic Cardiology Solution, Connex® Cardio ECG

Frost & Sullivan
Posted on: 01 Nov 18
Welch Allyn Earns Acclaim from Frost & Sullivan for Developing Its Innovative Diagnostic Cardiology Solution, Connex® Cardio ECG

PR Newswire

SANTA CLARA, Calif., Nov. 1, 2018

The Connex Cardio ECG demonstrates exceptional usability with advanced analysis and interpretation

SANTA CLARA, Calif., Nov. 1, 2018 /PRNewswire/ -- Based on its recent analysis of the North America diagnostic cardiology market, Frost & Sullivan recognizes Welch Allyn, a subsidiary of Hill-Rom, with the 2018 North America Technology Innovation Award for its industry-leading and clinically validated cardiology solutions. The company's innovative diagnostic algorithms, electronic medical record (EMR) connectivity and integration, and enhanced security features offer unparalleled client value, innovation, and ease of use. With the 2017 acquisition of Mortara Instrument, a leading diagnostic cardiology and patient monitoring technology provider, the company gained the capabilities to help clinicians further reduce the number of steps it takes to perform an electrocardiogram (ECG), helping to increase accuracy and workflow integration.

"In 2017, Welch Allyn launched the Connex® Cardio ECG, the company's first cardiology product introduction since the Mortara acquisition. The Connex Cardio ECG is a 12-lead ECG that combines the VERITAS® algorithm with wireless technology and flexible EMR connectivity to capture ECGs," said Patrick Riley, Principal Consultant at Frost & Sullivan. "The VERITAS algorithm—the same one used by the FDA to evaluate drug safety in clinical trials—analyzes and interprets the ECG reading, and the system then prints, stores, and transmits the results to the EMR. The resulting ECG can simplify clinicians' decision-making and workflows in one of the most commonly performed tests they do in the office every day."

The Connex Cardio ECG can offer such superior and wireless ECG capture by employing the unique WAM™ Wireless Acquisition Module. The system is highly scalable yet simple and can launch directly from the EMR to acquire ECGs in real time.

Regional health systems have already started standardizing their devices with the Connex Cardio ECG, and on the back of this success, Welch Allyn is preparing for global distribution.

"Welch Allyn has cutting-edge data security, which is a powerful purchase influencer among increasingly security-conscious customers. Data is translated and transported to diverse software systems and formats via DICOM® and Health Level Seven International communication standards," noted Riley. "The company's breadth of connectivity is an equally strong value proposition, as it allows devices to work with multiple systems in the hospital and beyond."

Each year, Frost & Sullivan presents this award to the company that develops a product with innovative features and functionality that is gaining rapid acceptance in the market. The award recognizes the quality of the solution and the customer value enhancements it enables.

Frost & Sullivan Best Practices awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research to identify best practices in the industry.

About Hill-Rom

Hill-Rom is a leading global medical technology company with more than 10,000 employees worldwide. We partner with health care providers in more than 100 countries, across all care settings, by focusing on patient care solutions that improve clinical and economic outcomes in five core areas: Advancing Mobility, Wound Care and Prevention, Patient Monitoring and Diagnostics, Surgical Safety and Efficiency and Respiratory Health. Our innovations ensure caregivers have the products they need to help diagnose, treat and protect their patients; speed up recoveries; and manage conditions. Every day, around the world, we enhance outcomes for patients and their caregivers. Learn more at hill-rom.com.

About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector, and the investment community. Contact us: Start the discussion.

Contact:

Samantha Park
P: 210.247.2426
F: 210.348.1003
E: samantha.park@frost.com

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/welch-allyn-earns-acclaim-from-frost--sullivan-for-developing-its-innovative-diagnostic-cardiology-solution-connex-cardio-ecg-300739727.html

SOURCE Frost & Sullivan

PR Newswire
www.prnewswire.com

Last updated on: 01/11/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.